1. Home
  2. ZURA vs ATOM Comparison

ZURA vs ATOM Comparison

Compare ZURA & ATOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZURA
  • ATOM
  • Stock Information
  • Founded
  • ZURA 2022
  • ATOM 2001
  • Country
  • ZURA United States
  • ATOM United States
  • Employees
  • ZURA N/A
  • ATOM N/A
  • Industry
  • ZURA Biotechnology: Biological Products (No Diagnostic Substances)
  • ATOM Semiconductors
  • Sector
  • ZURA Health Care
  • ATOM Technology
  • Exchange
  • ZURA Nasdaq
  • ATOM Nasdaq
  • Market Cap
  • ZURA 137.2M
  • ATOM 142.0M
  • IPO Year
  • ZURA N/A
  • ATOM 2016
  • Fundamental
  • Price
  • ZURA $3.34
  • ATOM $2.90
  • Analyst Decision
  • ZURA Buy
  • ATOM
  • Analyst Count
  • ZURA 9
  • ATOM 0
  • Target Price
  • ZURA $11.00
  • ATOM N/A
  • AVG Volume (30 Days)
  • ZURA 4.3M
  • ATOM 702.4K
  • Earning Date
  • ZURA 11-06-2025
  • ATOM 10-28-2025
  • Dividend Yield
  • ZURA N/A
  • ATOM N/A
  • EPS Growth
  • ZURA N/A
  • ATOM N/A
  • EPS
  • ZURA N/A
  • ATOM N/A
  • Revenue
  • ZURA N/A
  • ATOM $49,000.00
  • Revenue This Year
  • ZURA N/A
  • ATOM N/A
  • Revenue Next Year
  • ZURA N/A
  • ATOM $700.00
  • P/E Ratio
  • ZURA N/A
  • ATOM N/A
  • Revenue Growth
  • ZURA N/A
  • ATOM N/A
  • 52 Week Low
  • ZURA $0.97
  • ATOM $2.54
  • 52 Week High
  • ZURA $4.96
  • ATOM $17.55
  • Technical
  • Relative Strength Index (RSI)
  • ZURA 55.62
  • ATOM 31.05
  • Support Level
  • ZURA $3.18
  • ATOM $4.20
  • Resistance Level
  • ZURA $3.51
  • ATOM $4.90
  • Average True Range (ATR)
  • ZURA 0.36
  • ATOM 0.41
  • MACD
  • ZURA -0.08
  • ATOM -0.17
  • Stochastic Oscillator
  • ZURA 50.40
  • ATOM 14.56

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.

About ATOM Atomera Incorporated

Atomera Inc is engaged in the business of developing, commercializing, and licensing proprietary processes and technologies for the semiconductor industry. The company's technology, named Mears Silicon Technology, or MST, is a thin film of re-engineered silicon, typically 100 to 300 angstroms (or approximately 20 to 60 silicon atomic unit cells) thick. MST can be applied as a transistor channel enhancement to CMOS-type transistors, the majority of widely used transistor types in the semiconductor industry. The mears silicon technology of the company can be used for applications like Analog, DRAM, logic and processors, and SRAM.

Share on Social Networks: